Man Collapses During Trump’s Oval Office Announcement
During an Oval Office press conference on Thursday, a man collapsed behind President Donald Trump as he announced a deal with drugmakers to expand coverage and reduce prices for popular obesity treatments Zepbound and Wegovy. The event was held with representatives from Eli Lilly and Novo Nordisk.
Officials quickly responded to the incident, with Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz supporting the man's head as he was helped to the floor. The cause of the collapse was unclear.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.” – White House press secretary Karoline Leavitt
The man was later identified as a guest of one of the attending health care companies. He did not return to the event after the incident.
About an hour after the collapse, President Trump resumed the weight-loss drug event, noting the man was feeling lightheaded but was now okay. Newsweek has contacted the White House for further comments.
Trump’s Announcement
President Trump revealed a new agreement with Eli Lilly and Novo Nordisk aimed at expanding Medicare coverage and lowering costs for Zepbound and Wegovy, two widely used medications for obesity treatment.
This initiative is intended to increase access to effective obesity drugs for Medicare beneficiaries, addressing a growing health concern.
Summary
The press conference was briefly interrupted when a company representative fainted, but it resumed after medical assistance and reassurance from officials. The announcement highlights efforts to improve affordability and coverage for obesity medications.
Author’s summary: A company representative fainted during President Trump’s obesity drug announcement but quickly recovered, as Trump unveiled plans to expand Medicare coverage and cut prices for key treatments.